期刊文献+

RASSF1A在乳腺癌中表达及临床意义 被引量:1

Analysis of RASSF1A expression in breast cancer and its clinical significance
下载PDF
导出
摘要 目的研究乳腺癌及癌旁组织中RASSF1A的表达情况,并探讨其与临床、病理资料的相关性。方法收集60例乳腺癌及相应癌旁组织,通过免疫组化染色检测RASSF1A的表达情况;统计60例临床病例的各项临床、病理资料,并分析其相关性。结果 RASSF1A在乳腺癌组织中的表达阳性率为35%(21/60),而在癌旁组织中86.7%(52/60),癌旁组织中RASSF1A的表达明显高于乳腺癌组织(P<0.05);RASSF1A的表达与淋巴结转移有无、组织学分级、脉管侵犯、人类表皮生长因子受体2(HER-2)、Ki-67表达有关;TMN分期中的Ⅰ期、Ⅱ期以及部分ⅢA期(T3N1MO)患者RASSF1A表达48.4%(15/31)高于Ⅲ期(除T3N1MO外)患者20.7%(6/29)(χ2=5.053,P=0.025)。结论相较于癌旁组织,乳腺癌组织中存在RASSF1A表达缺失的情况,其缺失表达与和淋巴结转移有无、组织学分级、脉管侵犯、HER-2、Ki-67、TMN分期密切相关。 Objective To study the expression of RASSF1A in breast cancer and adjacent tissues,and to investigate the correlation between the expression of RASSF1A and clinical and pathological parameters.Methods Sixty cases of breast cancer and corresponding adjacent tissues were collected.The expression of RASSF1A was detected by immunohistochemical staining.The clinical and pathological parameters of 60 cases were collected and analyzed.Results The positive rate of RASSF1A expression in breast cancer tissues was35%(21/60),and 86.7%(52/60) in the adjacent tissues.The positive rate of RASSF1A expression in adjacent tissues was significantly higher than that in the breast cancer tissues(P < 0.05).The expression of RASSF1A was correlated with lymph node metastasis,histological grade,vascular invasion,HER-2 and Ki-67.The positive rate of RASSF1A expression was 48.4%(15/31) in the stageⅠ,Ⅱand Ⅲ A(T3N1MO),and it was 20.7%(6/29) in patients with stage Ⅲ(except for T3N1MO)(χ2= 5.053,P = 0.025).Conclusions The expression of RASSF1A is absent in the breast cancer tissues compared with the adjacent tissues.It was correlated with lymph node metastasis,histological grade,vascular invasion,HER-2,Ki-67 and TMN stage.
出处 《安徽医药》 CAS 2018年第3期463-466,共4页 Anhui Medical and Pharmaceutical Journal
基金 安徽医科大学校科研基金联合资助项目(2015xkj111)
关键词 RASSF1A 乳腺癌 临床意义 RASSF1A breast cancer clinical significance
  • 相关文献

参考文献2

二级参考文献23

  • 1Williamson EA, Wolf I, KellyJ , et al. BRCAI and FOXAI proteins co-regulate the expression of the cell cycle - dependent kinase inhihitor p27Kipl[J]. Oncogene ,2006 ,25 (9) : 1391 -1399.
  • 2LaganiereJ, Deblois G, Lefebvre C, et al. Location analysis of estrogen receptor a target promoters reveals that FOXAI defines a domain of the estrogen response[J] . Biochemistry, 2005 ,102 ( 33 ) : 11651 -11656.
  • 3Berry DA. Estrogen-receptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer[J] .JAMA, 2006,295 (14) : 1658 -1667.
  • 4Badve S, Turbin D, Thorat MA, et al. FOXAI expression in breast cancer - correlation with luminal subtype A and surrvival[J] . Clin Cancer Res,2007 ,13(15 Pt I) :4415 -4421.
  • 5Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J] . Annals of Oncology, 20 11 ,22 ( 8 ) : 1736 -1742.
  • 6CarrollJS, Liu XS, Brodsky As, et al. Chromosome-wide mapping of estrogen receptor binding reveals long - range regulation requiring the forkhead protein Foxal[J]. Cell,2005,122(1) :33 -43.
  • 7CarrollJS, Brown M. Estrogen receptor target gene: an evolving conceptJ J}, Mol Endocrinol,2006,20(8) :1707 -1714.
  • 8Wolf I, Bose S, Williamson EA,et al. FOXAi : growth inhibitor and a favorable prognostic factor in human breast cancer[J]. IntJ Cancer,2007 ,120(5) :1013 -1022.
  • 9Thorat MA, Marchio C, Morimiya A, et al. Forkhead box Ai expression in breast cancer is associated with luminal subtype and good prognosis[J].J Clin Pathol,2008,61 (3) :327 -332.
  • 10Habashy HO, Powe DG, Rakha EA, et al. Forkhead-box Al ( FOXAI ) expression in breast cancer and its prognostic significancelJ J. EurJ Cancer ,2008 ,44( 11) : 1541 -1551.

共引文献1044

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部